Kagan A R, Gilbert H A
Cancer Clin Trials. 1978 Winter;1(4):305-6.
A number of studies are considered in order to evaluate the benefits of combined treatment for patients with Stage B2C transitional carcinoma of the bladder. It is found that for a variety of reasons, such treatment is not shown to be beneficial; the conclusion is that routine combined preoperative therapy is investigative but cannot be recommended as a community standard.
为了评估联合治疗对B2C期膀胱移行癌患者的益处，进行了多项研究。结果发现，由于各种原因，这种治疗并未显示出有益效果；结论是，常规术前联合治疗仍处于研究阶段，不能作为社区标准推荐使用。
